Nerve Stimulators Market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 3.2 billion by 2030. The market is driven by factors such as increasing prevalence of chronic pain and neurological disorders, rising demand for minimally invasive surgeries, and technological advancements in nerve stimulation devices.
The global nerve stimulator market is segmented on the basis of type into nerve stimulation and nerve monitoring; on the basis of application into ESU (electro surgery unit) and electro surgery; and on the basis of region into North America, Latin America, Europe, Asia Pacific (APAC), Middle East & Africa (MEA). The North American region dominates the global market with a share of over 40%. This can be attributed to high adoption rates in this region owing to its advanced healthcare infrastructure coupled with high disposable income levels among people.
Some Of The Growth Factors Of This Market:
- The global population is increasing and aging, which will lead to an increase in the number of people with chronic pain.
- The prevalence of obesity is increasing globally, which leads to a higher incidence of diabetes and other chronic conditions that can cause nerve damage.
- Advances in technology have led to more effective treatments for nerve damage, such as nerve stimulators, which will lead to increased demand for these devices over time.
- As the population ages and becomes more affluent, there will be an increase in demand for medical devices that are not covered by insurance or government programs such as Medicare or Medicaid; this includes nerve stimulators because they are not typically covered by insurance plans but can be expensive without coverage (e.g., $5-10K).
- There has been a shift from hospital-based care towards outpatient care; this means that patients who need treatment for chronic pain may require less frequent visits to hospitals and clinics where they would otherwise receive treatment with a nerve stimulator device; this could lead to increased demand for these devices over time.
Industry Growth Insights published a new data on “Nerve Stimulators Market”. The research report is titled “Nerve Stimulators Market research by Types (Nerve Stimulation, Nerve Monitoring), By Applications (ESU, Electro Surgery), By Players/Companies Erbe Elektromedizin, Inomed Medizintechnik, EMS Biomedical, Neurosign, Nihon Kohden, Natus Medical Incorporated, Dr.Langer Medical, Bovie Medical, Inmed Equipments, Micromar, Checkpoint Surgical, ITC - International Technology Corporation”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Nerve Stimulators Market Research Report
By Type
Nerve Stimulation, Nerve Monitoring
By Application
ESU, Electro Surgery
By Companies
Erbe Elektromedizin, Inomed Medizintechnik, EMS Biomedical, Neurosign, Nihon Kohden, Natus Medical Incorporated, Dr.Langer Medical, Bovie Medical, Inmed Equipments, Micromar, Checkpoint Surgical, ITC - International Technology Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Nerve Stimulators Market Report Segments:
The global Nerve Stimulators market is segmented on the basis of:
Types
Nerve Stimulation, Nerve Monitoring
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
ESU, Electro Surgery
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Erbe Elektromedizin
- Inomed Medizintechnik
- EMS Biomedical
- Neurosign
- Nihon Kohden
- Natus Medical Incorporated
- Dr.Langer Medical
- Bovie Medical
- Inmed Equipments
- Micromar
- Checkpoint Surgical
- ITC - International Technology Corporation
Highlights of The Nerve Stimulators Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nerve Stimulation
- Nerve Monitoring
- By Application:
- ESU
- Electro Surgery
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nerve Stimulators Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nerve stimulators are medical devices that are used to treat conditions such as chronic pain, nerve damage, and other medical problems. They work by sending electrical impulses through the nerves.
Some of the major companies in the nerve stimulators market are Erbe Elektromedizin, Inomed Medizintechnik, EMS Biomedical, Neurosign, Nihon Kohden, Natus Medical Incorporated, Dr.Langer Medical, Bovie Medical, Inmed Equipments, Micromar, Checkpoint Surgical, ITC - International Technology Corporation.
The nerve stimulators market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nerve Stimulators Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Nerve Stimulators Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Nerve Stimulators Market - Supply Chain
4.5. Global Nerve Stimulators Market Forecast
4.5.1. Nerve Stimulators Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Nerve Stimulators Market Size (000 Units) and Y-o-Y Growth
4.5.3. Nerve Stimulators Market Absolute $ Opportunity
5. Global Nerve Stimulators Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Nerve Stimulators Market Size and Volume Forecast by Type
5.3.1. Nerve Stimulation
5.3.2. Nerve Monitoring
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Nerve Stimulators Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Nerve Stimulators Market Size and Volume Forecast by Application
6.3.1. ESU
6.3.2. Electro Surgery
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Nerve Stimulators Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Nerve Stimulators Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Nerve Stimulators Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Nerve Stimulators Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Nerve Stimulators Demand Share Forecast, 2019-2026
9. North America Nerve Stimulators Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Nerve Stimulators Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Nerve Stimulators Market Size and Volume Forecast by Application
9.4.1. ESU
9.4.2. Electro Surgery
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Nerve Stimulators Market Size and Volume Forecast by Type
9.7.1. Nerve Stimulation
9.7.2. Nerve Monitoring
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Nerve Stimulators Demand Share Forecast, 2019-2026
10. Latin America Nerve Stimulators Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Nerve Stimulators Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Nerve Stimulators Market Size and Volume Forecast by Application
10.4.1. ESU
10.4.2. Electro Surgery
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Nerve Stimulators Market Size and Volume Forecast by Type
10.7.1. Nerve Stimulation
10.7.2. Nerve Monitoring
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Nerve Stimulators Demand Share Forecast, 2019-2026
11. Europe Nerve Stimulators Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Nerve Stimulators Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Nerve Stimulators Market Size and Volume Forecast by Application
11.4.1. ESU
11.4.2. Electro Surgery
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Nerve Stimulators Market Size and Volume Forecast by Type
11.7.1. Nerve Stimulation
11.7.2. Nerve Monitoring
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Nerve Stimulators Demand Share, 2019-2026
12. Asia Pacific Nerve Stimulators Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Nerve Stimulators Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Nerve Stimulators Market Size and Volume Forecast by Application
12.4.1. ESU
12.4.2. Electro Surgery
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Nerve Stimulators Market Size and Volume Forecast by Type
12.7.1. Nerve Stimulation
12.7.2. Nerve Monitoring
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Nerve Stimulators Demand Share, 2019-2026
13. Middle East & Africa Nerve Stimulators Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Nerve Stimulators Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Nerve Stimulators Market Size and Volume Forecast by Application
13.4.1. ESU
13.4.2. Electro Surgery
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Nerve Stimulators Market Size and Volume Forecast by Type
13.7.1. Nerve Stimulation
13.7.2. Nerve Monitoring
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Nerve Stimulators Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Nerve Stimulators Market: Market Share Analysis
14.2. Nerve Stimulators Distributors and Customers
14.3. Nerve Stimulators Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Erbe Elektromedizin
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Inomed Medizintechnik
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. EMS Biomedical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Neurosign
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Nihon Kohden
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Natus Medical Incorporated
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Dr.Langer Medical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bovie Medical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Inmed Equipments
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Micromar
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Checkpoint Surgical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. ITC - International Technology Corporation
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
